The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A novel and simple KRAS mutation detection method, FRET-Based Preferential Homoduplex Formation Assay (f-PHFA): Results from a multicenter, clinical evaluation trial.
Kensei Yamaguchi
No relevant relationships to disclose
Kiwamu Akagi
No relevant relationships to disclose
Miho Kakuta
No relevant relationships to disclose
Masafumi Kurosumi
No relevant relationships to disclose
Yoji Nishimura
No relevant relationships to disclose
Norio Saito
No relevant relationships to disclose
Motohiro Kojima
No relevant relationships to disclose
Atsushi Ochiai
No relevant relationships to disclose
Atsushi Ohtsu
No relevant relationships to disclose
Takayuki Yoshino
No relevant relationships to disclose